Quantbot Technologies’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-7,453
| Closed | -$199K | – | 1653 |
|
|
2025
Q4 | $199K | Sell |
7,453
-18,611
| -71% | -$445K | 0.01% | 1238 |
|
|
2025
Q3 | $556K | Buy |
+26,064
| New | +$616K | 0.02% | 984 |
|
|
2025
Q2 | – | Sell |
-3,142
| Closed | -$52.2K | – | 1596 |
|
|
2025
Q1 | $52.2K | Buy |
+3,142
| New | +$57.1K | ﹤0.01% | 1319 |
|
|
2024
Q2 | – | Sell |
-900
| Closed | -$16.6K | – | 1377 |
|
|
2024
Q1 | $16.6K | Sell |
900
-14,650
| -94% | -$363K | ﹤0.01% | 1426 |
|
|
2023
Q4 | $487K | Buy |
+15,550
| New | +$371K | 0.03% | 741 |
|
|
2023
Q3 | – | Sell |
-12,834
| Closed | -$307K | – | 1490 |
|
|
2023
Q2 | $307K | Sell |
12,834
-9,549
| -43% | -$212K | 0.02% | 826 |
|
|
2023
Q1 | $421K | Buy |
+22,383
| New | +$426K | 0.03% | 668 |
|
|
2022
Q3 | – | Sell |
-20,294
| Closed | -$285K | – | 1539 |
|
|
2022
Q2 | $285K | Buy |
20,294
+2,621
| +15% | +$48.9K | 0.03% | 785 |
|
|
2022
Q1 | $428K | Buy |
+17,673
| New | +$428K | 0.04% | 637 |
|
|
2021
Q4 | – | Sell |
-12,100
| Closed | -$200K | – | 1442 |
|
|
2021
Q3 | $200K | Buy |
12,100
+11,919
| +6,585% | +$230K | 0.01% | 805 |
|
|
2021
Q2 | $4K | Buy |
+181
| New | +$4.08K | ﹤0.01% | 1374 |
|
|
2021
Q1 | – | Sell |
-121
| Closed | -$6K | – | 1359 |
|
|
2020
Q4 | $6K | Sell |
121
-716
| -86% | -$35.5K | ﹤0.01% | 1144 |
|
|
2020
Q3 | $34K | Buy |
837
+696
| +494% | +$30.1K | ﹤0.01% | 919 |
|
|
2020
Q2 | $6K | Sell |
141
-39
| -22% | -$1.87K | ﹤0.01% | 980 |
|
|
2020
Q1 | $7K | Sell |
180
-12,607
| -99% | -$519K | ﹤0.01% | 724 |
|
|
2019
Q4 | $547K | Buy |
12,787
+6,547
| +105% | +$285K | 0.05% | 383 |
|
|
2019
Q3 | $224K | Buy |
+6,240
| New | +$189K | 0.02% | 670 |
|
|
2018
Q2 | – | Sell |
-6,600
| Closed | -$148K | – | 1155 |
|
|
2018
Q1 | $148K | Buy |
6,600
+1,790
| +37% | +$49.6K | 0.01% | 759 |
|
|
2017
Q4 | $144K | Buy |
4,810
+1,088
| +29% | +$34.8K | 0.01% | 775 |
|
|
2017
Q3 | $140K | Sell |
3,722
-6,851
| -65% | -$223K | 0.01% | 773 |
|
|
2017
Q2 | $294K | Buy |
+10,573
| New | +$315K | 0.03% | 566 |
|
|
2015
Q1 | – | Sell |
-1,553
| Closed | -$49K | – | 1021 |
|
|
2014
Q4 | $49K | Sell |
1,553
-5,718
| -79% | -$162K | 0.02% | 831 |
|
|
2014
Q3 | $180K | Buy |
7,271
+3,344
| +85% | +$78.2K | 0.02% | 730 |
|
|
2014
Q2 | $88K | Buy |
3,927
+2,527
| +181% | +$52.8K | 0.01% | 776 |
|
|
2014
Q1 | $34K | Buy |
+1,400
| New | +$35.4K | 0.01% | 872 |
|
Other funds holding ACAD
BBA
RI
PAI
Quantbot Technologies's ACAD Position: Q1 2026 in Review
Quantbot Technologies sold out of Acadia Pharmaceuticals (ACAD) in Q1 2026, closing a stake of 7,453 shares — an estimated $199K sold.
Quantbot Technologies first reported a position in ACAD in Q1 2014 and held it in 25 quarters. The position peaked at $556K in Q3 2025. 343 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.
- Quantbot Technologies reported no remaining Acadia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Quantbot Technologies sold 7,453 Acadia Pharmaceuticals shares in Q1 2026, an estimated $199K.
- Quantbot Technologies first reported a position in Acadia Pharmaceuticals in Q1 2014 and held it in 25 quarters.
- Quantbot Technologies's Acadia Pharmaceuticals position peaked at $556K in Q3 2025.
- 343 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.
Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.